跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
在 國立陽明交通大學研發優勢分析平台 搜尋內容
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
查看斯高帕斯 (Scopus) 概要
陳 怡仁
教授
醫學系婦產學科
電子郵件
chenyj
vghtpe.gov
tw
h-index
h10-index
h5-index
5363
引文
37
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
3004
引文
26
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
877
引文
16
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2000
2025
每年研究成果
概覽
指紋
網路
研究成果
(202)
類似的個人檔案
(6)
指紋
查看啟用 Yi-Jen Chen 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Taiwan
55%
Arrhythmogenesis
51%
Endometriosis
51%
Calcium Homeostasis
49%
Pulmonary Vein
43%
Retrospective Cohort Study
35%
Right Ventricular Outflow Tract
34%
Epithelial Ovarian Cancer
32%
95% Confidence Interval
32%
Induced Pluripotent Stem Cells (iPSCs)
30%
Fibrogenesis
28%
Taiwanese
26%
Endometrial Cancer
26%
Ca2+
25%
Adenomyosis
25%
Myomectomy
25%
Uterine Sarcoma
24%
Atrial Fibrillation
23%
Estrogen
23%
Postmenopausal Women
23%
Obstetrics
23%
Overall Survival
22%
Laparoscopic Myomectomy
22%
Laparoscopic Surgery
21%
Human Atrial Fibroblasts
21%
Atrial Arrhythmogenesis
20%
Cisplatin
20%
Profibrotic
20%
Cardiomyocytes
19%
Angiogenesis
19%
Vascular Endothelial Growth Factor
19%
Ovarian Cancer
19%
Electrical Activity
19%
Fibroblasts
19%
Single Port
18%
Fallopian Tube Carcinoma
18%
Bipolar Coagulation
18%
Uterine Vessels
18%
Rare Case Report
18%
Spike Protein
18%
Ventricular Arrhythmia
18%
Heart Failure
18%
Action Potential Duration
17%
Operative Time
17%
Gonadotropin-releasing Hormone
16%
Randomized Controlled Trial
16%
Odds Ratio
16%
Chronic Kidney Disease
16%
Cervical Cancer
16%
Cardiac Fibroblasts
15%
Medicine and Dentistry
Krukenberg Tumor
49%
Recurrent Disease
47%
Uterine Cancer
46%
Retrospective Cohort Study
45%
Systematic Review
43%
Uterine Myomectomy
41%
Myoma
41%
Endometriosis
39%
Overall Survival
37%
Arrhythmogenesis
32%
Cervical Cancer
27%
Gestational Age
26%
Neoplasm
26%
Chemotherapy
25%
Cystectomy
25%
Laparoscopic Surgery
25%
Cisplatin
24%
Uterus Sarcoma
24%
Stress Incontinence
24%
Gynecology
23%
Diseases
22%
Calcium Ion
22%
Cancer
21%
Cytoreductive Surgery
20%
Uterine Fibroid
20%
Ovarian Cancer
19%
Clear Cell Carcinoma
19%
Pelvis
19%
Fibroblast
18%
Calcium Homeostasis
18%
Uterine Tube Carcinoma
18%
Morcellation
18%
Adenocarcinoma
18%
Bleeding
18%
Progression Free Survival
18%
Prognostic Factor
17%
Platinum
17%
Menorrhagia
17%
Obstetrics
17%
Doppler Ultrasound
17%
Doppler Flowmetry
17%
Dentigerous Cyst
16%
First Trimester Pregnancy
16%
Recurrence Risk
16%
Adverse Event
16%
Randomized Controlled Trial
15%
Carcinoma
14%
Adenomyosis
14%
Disease Free Survival
14%
Squamous Cell Carcinoma
13%
Pharmacology, Toxicology and Pharmaceutical Science
Arrhythmogenesis
100%
Calcium Ion
61%
Atrial Fibrillation
41%
Endometriosis
39%
Rat
35%
Sodium
28%
Leporidae
27%
Adenomyosis
24%
Western Blot
23%
Recurrent Disease
23%
Heart Ventricle Arrhythmia
23%
Heart Ventricle Tachycardia
21%
Congestive Heart Failure
20%
Heart Ventricle Remodeling
19%
Fibrosis
18%
Vasculotropin
18%
Receptor
17%
Estrogen
17%
Ovary Carcinoma
17%
Sodium Ion
16%
Cyclooxygenase 2
15%
Diabetes Mellitus
15%
Chronic Kidney Failure
14%
Levonorgestrel
14%
Chemotherapy Regimens
13%
Protein Kinase B
12%
Reactive Oxygen Metabolite
12%
Empagliflozin
12%
Cisplatin
12%
Wound Healing
12%
Paclitaxel
12%
Stress Incontinence
12%
Endometrium Tumor
12%
Nitric Oxide
12%
Isoprenaline
11%
Diseases
11%
Adenosine Triphosphate
11%
Inflammation
11%
Lecithinase
10%
Heart Atrium Arrhythmia
10%
Cytokine
10%
Phosphotransferase
9%
Calcium Calmodulin Dependent Protein Kinase II
9%
Pathogenesis
9%
Gonadorelin Agonist
9%
Procollagen
8%
Overall Survival
8%
Platinum
8%
Dysmenorrhea
8%
Immunoglobulin Enhancer Binding Protein
8%
